Recurrent Malignant Testicular Germ Cell Tumor Terminated Phase 2 Trials for Palifosfamide (DB05668)

IndicationStatusPhase
DBCOND0028803 (Recurrent Malignant Testicular Germ Cell Tumor)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01808534Palifosfamide in Treating Patients With Recurrent Germ Cell TumorsTreatment